• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二肽基肽酶IV的刚性与柔性:DPIV的晶体结构及对接实验

Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV.

作者信息

Engel Michael, Hoffmann Torsten, Manhart Susanne, Heiser Ulrich, Chambre Sylvie, Huber Robert, Demuth Hans-Ulrich, Bode Wolfram

机构信息

Max-Planck-Institut für Biochemie, AG Proteinaseforschung, Am Klopferspitz 18, D-82152 Martinsried, Germany.

出版信息

J Mol Biol. 2006 Jan 27;355(4):768-83. doi: 10.1016/j.jmb.2005.11.014. Epub 2005 Nov 22.

DOI:10.1016/j.jmb.2005.11.014
PMID:16330047
Abstract

Dipeptidyl peptidase IV (DPIV) is an alpha,beta-hydrolase-like serine exopeptidase, which removes dipeptides, preferentially with a C-terminal l-Pro residue, from the N terminus of longer peptide substrates. Previously, we determined the tetrameric 1.8A crystal structure of native porcine DPIV. Each monomer is composed of a beta-propeller and a catalytic domain, which together embrace an internal cavity housing the active centre. This cavity is connected to the bulk solvent by a "propeller opening" and a "side opening". Here, we analyse DPIV complexes with a t-butyl-Gly-Pro-Ile tripeptide, Pro-boroPro, a piperazine purine compound, and aminoethyl phenyl sulfonylfluoride. The latter two compounds bind to the active-site groove in a compact and a quite bulky manner, respectively, causing considerable shifts of the catalytic Ser630 side-chain and of the Tyr547 phenolic group, which forms the oxyanion hole. The tripeptide, mimicking a peptide substrate, is clamped to the active site through tight interactions via its N-terminal alpha-ammonium group, the P2 carbonyl group, the P1-l-Pro side-chain, the C-terminal carboxylate group, and the stable orthoacid ester amide formed between the scissile peptide carbonyl group and Ser630 O(gamma). This stable trapping of the tripeptide could be due to stabilization of the protonated His740 imidazolium cation by the adjacent negatively charged C-terminal carboxylate group, preventing proton transfer to the leaving group nitrogen atom. Docking experiments with the compact rigid 58 residue protein aprotinin, which had been shown to be processed by DPIV, indicate that the Arg1-Pro2 N terminus can access the DPIV active site only upon widening of its side openings, probably by separation of the first and the last propeller blades, and/or of the catalytic and the propeller domain.

摘要

二肽基肽酶IV(DPIV)是一种α,β-水解酶样丝氨酸外肽酶,它从较长肽底物的N末端去除二肽,优先去除带有C末端L-脯氨酸残基的二肽。此前,我们确定了天然猪DPIV的四聚体1.8埃晶体结构。每个单体由一个β-螺旋桨和一个催化结构域组成,它们共同围绕着一个容纳活性中心的内部腔室。这个腔室通过一个“螺旋桨开口”和一个“侧面开口”与大量溶剂相连。在这里,我们分析了DPIV与叔丁基-甘氨酰-脯氨酰-异亮氨酸三肽、脯氨硼硼烷、一种哌嗪嘌呤化合物以及氨乙基苯磺酰氟的复合物。后两种化合物分别以紧密和相当庞大的方式结合到活性位点凹槽中,导致催化性丝氨酸630侧链和形成氧负离子洞的酪氨酸547酚基团发生相当大的位移。该三肽模拟肽底物,通过其N末端α-铵基团、P2羰基、P1-L-脯氨酸侧链、C末端羧基以及在可裂解肽羰基和丝氨酸630 O(γ)之间形成的稳定原酸酯酰胺之间的紧密相互作用被夹在活性位点上。这种三肽的稳定捕获可能是由于相邻带负电荷的C末端羧基对质子化的组氨酸740咪唑阳离子的稳定作用,从而防止质子转移到离去基团氮原子上。对已被证明可被DPIV加工的紧凑刚性58残基蛋白质抑肽酶进行对接实验表明,只有在其侧面开口变宽时,精氨酸1-脯氨酸2 N末端才能进入DPIV活性位点,这可能是通过第一个和最后一个螺旋桨叶片的分离,和/或催化结构域和螺旋桨结构域的分离来实现的。

相似文献

1
Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV.二肽基肽酶IV的刚性与柔性:DPIV的晶体结构及对接实验
J Mol Biol. 2006 Jan 27;355(4):768-83. doi: 10.1016/j.jmb.2005.11.014. Epub 2005 Nov 22.
2
Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog.人二肽基肽酶IV/CD26与底物类似物复合物的晶体结构
Nat Struct Biol. 2003 Jan;10(1):19-25. doi: 10.1038/nsb882.
3
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders.细胞生物学和肝脏疾病中的二肽基肽酶IV及相关酶
Clin Sci (Lond). 2005 Apr;108(4):277-92. doi: 10.1042/CS20040302.
4
Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family.CD26/二肽基肽酶IV基因家族中催化、表达和二聚化的结构要求。
Biochemistry. 2003 Jan 28;42(3):694-701. doi: 10.1021/bi026846s.
5
The purification and characterisation of novel dipeptidyl peptidase IV-like activity from bovine serum.牛血清中新型二肽基肽酶IV样活性的纯化与表征
Int J Biochem Cell Biol. 2004 Jul;36(7):1281-96. doi: 10.1016/j.biocel.2003.02.001.
6
Flexibility of prolyl oligopeptidase: molecular dynamics and molecular framework analysis of the potential substrate pathways.脯氨酰寡肽酶的灵活性:潜在底物途径的分子动力学和分子框架分析
Proteins. 2005 Aug 15;60(3):504-12. doi: 10.1002/prot.20508.
7
Structure-function properties of prolyl oligopeptidase family enzymes.脯氨酰寡肽酶家族酶的结构-功能特性
Cell Biochem Biophys. 2006;44(3):349-65. doi: 10.1385/CBB:44:3:349.
8
Selectivity among dipeptidyl peptidases of the S9b family.S9b家族二肽基肽酶之间的选择性
Cell Mol Biol (Noisy-le-grand). 2006 Dec 31;52(4):3-7.
9
Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors.大鼠肾脏中DPP-IV(CD26)的晶体结构显示出对肽酶选择性抑制剂的灵活容纳。
Biochemistry. 2006 Jun 20;45(24):7474-82. doi: 10.1021/bi060184f.
10
Crystal structure and mechanism of tripeptidyl activity of prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis.牙龈卟啉单胞菌脯氨酰三肽基氨肽酶的晶体结构及三肽基活性机制
J Mol Biol. 2006 Sep 15;362(2):228-40. doi: 10.1016/j.jmb.2006.06.083. Epub 2006 Aug 17.

引用本文的文献

1
Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy.基于小分子:成纤维细胞活化蛋白抑制剂放射性药物在肿瘤精准治疗中的研发与应用
Front Pharmacol. 2025 May 14;16:1593380. doi: 10.3389/fphar.2025.1593380. eCollection 2025.
2
Τhiazolidine-4-One Derivatives with Variable Modes of Inhibitory Action Against DPP4, a Drug Target with Multiple Activities and Established Role in Diabetes Mellitus Type II.对二肽基肽酶4具有可变抑制作用模式的噻唑烷-4-酮衍生物,二肽基肽酶4是一种具有多种活性且在2型糖尿病中起既定作用的药物靶点。
Pharmaceuticals (Basel). 2025 Jan 4;18(1):52. doi: 10.3390/ph18010052.
3
Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions.
抑肽酶(II):用于治疗 COVID-19 和其他病毒病的吸入式给药。
Int J Mol Sci. 2024 Jun 29;25(13):7209. doi: 10.3390/ijms25137209.
4
Computational Modeling of the Interactions between DPP IV and Hemorphins.二肽基肽酶IV与血啡肽相互作用的计算模型
Int J Mol Sci. 2024 Mar 6;25(5):3059. doi: 10.3390/ijms25053059.
5
Survey of Dipeptidyl Peptidase III Inhibitors: From Small Molecules of Microbial or Synthetic Origin to Aprotinin.二肽基肽酶 III 抑制剂概述:从微生物或合成小分子起源到抑肽酶。
Molecules. 2022 May 7;27(9):3006. doi: 10.3390/molecules27093006.
6
New Bioactive Peptides Identified from a Tilapia Byproduct Hydrolysate Exerting Effects on DPP-IV Activity and Intestinal Hormones Regulation after Canine Gastrointestinal Simulated Digestion.从罗非鱼副产物水解物中鉴定出的新型生物活性肽在犬胃肠道模拟消化后对 DPP-IV 活性和肠道激素调节的影响。
Molecules. 2020 Dec 30;26(1):136. doi: 10.3390/molecules26010136.
7
The acid-base-nucleophile catalytic triad in ABH-fold enzymes is coordinated by a set of structural elements.ABH 折叠酶中的酸碱亲核催化三联体由一组结构元件协调。
PLoS One. 2020 Feb 21;15(2):e0229376. doi: 10.1371/journal.pone.0229376. eCollection 2020.
8
Molecular mechanism of polyketide shortening in anthraquinone biosynthesis of .[物种名称]蒽醌生物合成中聚酮缩短的分子机制
Chem Sci. 2019 May 14;10(25):6341-6349. doi: 10.1039/c9sc00749k. eCollection 2019 Jul 7.
9
Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues.细菌二肽基肽酶 IV 的晶体结构揭示了一种新颖的底物识别机制,与哺乳动物同源物的机制明显不同。
Sci Rep. 2018 Feb 9;8(1):2714. doi: 10.1038/s41598-018-21056-y.
10
The versatility of boron in biological target engagement.硼在生物靶标结合中的多功能性。
Nat Chem. 2017 Jul 25;9(8):731-742. doi: 10.1038/nchem.2814.